Markt oder Branche auswählen:
| Unternehmen / Aktien | News 24 h | News 7 T | Kurs | ||
|---|---|---|---|---|---|
| BIOGEN | 1 | 54 | -0,10 % | ||
| REGENERON PHARMACEUTICALS | 1 | 22 | -0,98 % | ||
| ALNYLAM PHARMACEUTICALS | 1 | 9 | -0,89 % | ||
| IMMUNITYBIO | 1 | 3 | +0,95 % | ||
| INNOVIVA | 1 | - | +2,84 % | ||
| MIND MEDICINE | 1 | - | -0,75 % | ||
| AMGEN | - | 27 | -0,79 % | ||
| INCYTE | - | 25 | -1,16 % | ||
| MONTE ROSA THERAPEUTICS | - | 21 | -1,51 % | ||
| EYEPOINT | - | 20 | +1,43 % |
- 24 h
- 7 Tage
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Sa | 2 Reasons to Buy Regeneron Stock Like There's No Tomorrow | 5 | The Motley Fool | ||
| Sa | ImmunityBio (IBRX) Climbs 7.76% on Europe Expansion | 4 | Insider Monkey | ||
| Sa | Lululemon, Biogen to exit Nasdaq 100 with Alnylam, Seagate among additions | 20 | Seeking Alpha | ||
| Sa | Neural Therapeutics mit Partner Hanf.com, MindMed und Tilray: Neue Chancen durch strengere Regeln im Cannabismarkt | Small- & Micro Cap Investment | |||
| Sa | FDA Approves Innoviva's NUZOLVENCE, First-in-Class Oral Treatment For Gonorrhea | 6 | RTTNews | ||
| Sa | Amgen CDR (CAD Hedged): Amgen CDR (CAD Hedged) declares dividend | 9 | Stockwatch | ||
| Fr | Alector Names Neil Berkley As Chief Financial Officer | 1 | RTTNews | ||
| Fr | Prothena Announces Board of Directors Update | 1 | City A.M. | ||
| Fr | Zevra Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) | 2 | GlobeNewswire (USA) | ||
| Fr | GSK beendet Partnerschaft: Ideaya Biosciences erhält Rechte für zwei Programme zurück | 4 | Investing.com Deutsch | ||
| Fr | Alector appoints Neil Berkley as chief financial officer | 1 | Seeking Alpha | ||
| Fr | Artiva Biotherapeutics, Inc. - 8-K, Current Report | - | SEC Filings | ||
| Fr | Paula Cobb steps down from Prothena's board to join Manifold Bio | 1 | Investing.com | ||
| Fr | Anavex Life Sciences Corp.: Anavex Life Sciences Provides Update on Regulatory Review in the EU for Blarcamesine to Treat Early Alzheimer's Disease | 89 | GlobeNewswire (Europe) | NEW YORK, Dec. 12, 2025 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. ("Anavex" or the "Company") (Nasdaq: AVXL), a clinical-stage biopharmaceutical company focused on developing innovative treatments... ► Artikel lesen | |
| Fr | Alector, Inc.: Alector Appoints Neil Berkley as Chief Financial Officer and Chief Business Officer | 75 | GlobeNewswire (Europe) | SOUTH SAN FRANCISCO, Calif., Dec. 12, 2025 (GLOBE NEWSWIRE) -- Alector, Inc. (Nasdaq: ALEC), a clinical-stage biotechnology company focused on developing therapies to counteract the devastating progression... ► Artikel lesen | |
| Fr | 4D Molecular Therapeutics, Inc.: 4DMT Announces New Employment Inducement Grants | 1 | GlobeNewswire (USA) | ||
| Fr | FDA endorses 2nd new gonorrhea treatment, clearing way for Innoviva's Nuzolvence | 2 | FiercePharma | ||
| Fr | Prothena Corporation plc: Prothena Announces Board of Directors Update | 230 | Business Wire | Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company with a robust pipeline of investigational therapeutics built on protein dysregulation expertise, today announced... ► Artikel lesen | |
| Fr | $100 Invested In Ascendis Pharma 10 Years Ago Would Be Worth This Much Today | 1 | Benzinga.com | ||
| Fr | Ascendis Pharma gains amid takeover speculation | 1 | Seeking Alpha |
1 2 3 4 5 Weiter >>
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .